Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

ACADIA Pharmaceuticals Inc.

NASDAQ: ACADHealthcare / Biotechnology / USA
22.82-0.1600-0.70%Vol 912 0121Y Perf -26.60%
Feb 20th, 2019 16:00
BID22.59 ASK23.49
Open23.02 Previous Close22.98
Pre-Market- After-Trading22.82
 - -%  - -%
Target Price
30.91 
Analyst Rating
Moderate Buy 1.73
Potencial %
35.45 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/71/80 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/98/98 
Growth Ranking
★★+     50.21
Insiders Shares Cnt. % 3/6/12M
-100/98/98 
Income Ranking
 —    -
Market Cap (mil)2 854 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
50.86 
Earnings Date
26th Feb 2019

Today's Price Range

22.5823.41

 

52wk Range

12.7732.53

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
8.31%
3 Months
21.51%
6 Months
61.73%
1 Year
-26.60%
3 Years
15.49%
5 Years
-20.87%

Quotes

Name / TickerPriceChg.Chg.%
ACAD22.82-0.1600-0.70
AAPL172.031.10000.64
GOOG1 113.80-4.7600-0.43
MSFT107.15-1.0200-0.94
XOM78.530.30000.38
WFC49.810.43000.87
JNJ136.350.66000.49
FB162.560.27000.17
GE10.10-0.0300-0.30
JPM105.690.51000.48
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.60
Current Ratio
6.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
94.20
EBIT Margin
-120.40
EBITDA Margin
-119.00
Pre-tax Profit Margin
-69 624.00
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
12.53
PS Ratios
16.70
Price to Cash Flow
-
Price to Free Cash Flow
-21.50
Cash Flow Per Share
-1.27
Price to Tangible Book
12.79
Book Value per Share
1.79
Enterprise Value (in ths.)
2 586 280
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-61.00
ROE last 12 Months
-83.29
Return on Assets (5Y Avg)
-51.89
ROA last 12 Months
-73.55
Return on Capital (5Y Avg)
-62.68
ROC last 12 Months
-82.75
Return on invested Capital Q
-25.46
Return on invested Capital Y
-67.80
Assets Turnover
0.50
Receivables Turnover
8.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
164 236
Revenue per Share
1.31
Revenue Growth 3 Years
1 182.90
Revenue Growth 5 Years
263.62
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.58-0.5013.79
Q02 2018-0.45-0.51-13.33
Q01 2018-0.56-0.4421.43
Q04 2017-0.58-0.555.17
Q03 2017-0.63-0.5315.87
Q02 2017-0.71-0.5522.54
Q01 2017-0.73-0.721.37
Q04 2016-0.65-0.650.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.551.79Positive
12/2018 FY-1.990.50Positive
3/2019 QR-0.560.00-
12/2019 FY-1.741.69Positive
Next Report Date26th Feb 2019
Estimated EPS Next Report-0.55
Estimates Count7
EPS Growth Next 5 Years %15.00
Volume Overview
Volume912 012
Shares Outstanding (in ths.)125 075
Trades Count5 277
Dollar Volume18 202 806
Avg. Volume1 564 650
Avg. Weekly Volume1 167 277
Avg. Monthly Volume1 326 009
Avg. Quarterly Volume1 925 941

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

40%60%

Bearish Bullish

62%38%

Bearish Bullish

62%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (63.64 %)
7 (63.64 %)
7 (70.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (36.36 %)
4 (36.36 %)
3 (30.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.73
Moderate Buy
1.73
Moderate Buy
1.60

There are no comments yet.

News